These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Similar Depletion of Protective Faecalibacterium prausnitzii in Psoriasis and Inflammatory Bowel Disease, but not in Hidradenitis Suppurativa. Eppinga H; Sperna Weiland CJ; Thio HB; van der Woude CJ; Nijsten TE; Peppelenbosch MP; Konstantinov SR J Crohns Colitis; 2016 Sep; 10(9):1067-75. PubMed ID: 26971052 [TBL] [Abstract][Full Text] [Related]
7. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Machiels K; Joossens M; Sabino J; De Preter V; Arijs I; Eeckhaut V; Ballet V; Claes K; Van Immerseel F; Verbeke K; Ferrante M; Verhaegen J; Rutgeerts P; Vermeire S Gut; 2014 Aug; 63(8):1275-83. PubMed ID: 24021287 [TBL] [Abstract][Full Text] [Related]
8. Gut microbiota differs between children with Inflammatory Bowel Disease and healthy siblings in taxonomic and functional composition: a metagenomic analysis. Knoll RL; Forslund K; Kultima JR; Meyer CU; Kullmer U; Sunagawa S; Bork P; Gehring S Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G327-G339. PubMed ID: 28039159 [TBL] [Abstract][Full Text] [Related]
9. Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Lee T; Clavel T; Smirnov K; Schmidt A; Lagkouvardos I; Walker A; Lucio M; Michalke B; Schmitt-Kopplin P; Fedorak R; Haller D Gut; 2017 May; 66(5):863-871. PubMed ID: 26848182 [TBL] [Abstract][Full Text] [Related]
10. Differences in Fecal Microbiomes and Metabolomes of People With vs Without Irritable Bowel Syndrome and Bile Acid Malabsorption. Jeffery IB; Das A; O'Herlihy E; Coughlan S; Cisek K; Moore M; Bradley F; Carty T; Pradhan M; Dwibedi C; Shanahan F; O'Toole PW Gastroenterology; 2020 Mar; 158(4):1016-1028.e8. PubMed ID: 31843589 [TBL] [Abstract][Full Text] [Related]
11. Analysis of the Association between Fatigue and the Plasma Lipidomic Profile of Inflammatory Bowel Disease Patients. Horta D; Moreno-Torres M; Ramírez-Lázaro MJ; Lario S; Kuligowski J; Sanjuan-Herráez JD; Quintas G; Villoria A; Calvet X J Proteome Res; 2021 Jan; 20(1):381-392. PubMed ID: 32969224 [TBL] [Abstract][Full Text] [Related]
13. Metaproteomics of fecal samples of Crohn's disease and Ulcerative Colitis. Lehmann T; Schallert K; Vilchez-Vargas R; Benndorf D; Püttker S; Sydor S; Schulz C; Bechmann L; Canbay A; Heidrich B; Reichl U; Link A; Heyer R J Proteomics; 2019 Jun; 201():93-103. PubMed ID: 31009805 [TBL] [Abstract][Full Text] [Related]
14. Low-Fat, High-Fiber Diet Reduces Markers of Inflammation and Dysbiosis and Improves Quality of Life in Patients With Ulcerative Colitis. Fritsch J; Garces L; Quintero MA; Pignac-Kobinger J; Santander AM; Fernández I; Ban YJ; Kwon D; Phillips MC; Knight K; Mao Q; Santaolalla R; Chen XS; Maruthamuthu M; Solis N; Damas OM; Kerman DH; Deshpande AR; Lewis JE; Chen C; Abreu MT Clin Gastroenterol Hepatol; 2021 Jun; 19(6):1189-1199.e30. PubMed ID: 32445952 [TBL] [Abstract][Full Text] [Related]
15. Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis. Paramsothy S; Nielsen S; Kamm MA; Deshpande NP; Faith JJ; Clemente JC; Paramsothy R; Walsh AJ; van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Lin E; Borody TJ; Wilkins MR; Colombel JF; Mitchell HM; Kaakoush NO Gastroenterology; 2019 Apr; 156(5):1440-1454.e2. PubMed ID: 30529583 [TBL] [Abstract][Full Text] [Related]
16. Altered profiles of fecal bile acids correlate with gut microbiota and inflammatory responses in patients with ulcerative colitis. Yang ZH; Liu F; Zhu XR; Suo FY; Jia ZJ; Yao SK World J Gastroenterol; 2021 Jun; 27(24):3609-3629. PubMed ID: 34239273 [TBL] [Abstract][Full Text] [Related]
17. Fecal Microbiota and Metabolome in a Mouse Model of Spontaneous Chronic Colitis: Relevance to Human Inflammatory Bowel Disease. Robinson AM; Gondalia SV; Karpe AV; Eri R; Beale DJ; Morrison PD; Palombo EA; Nurgali K Inflamm Bowel Dis; 2016 Dec; 22(12):2767-2787. PubMed ID: 27824648 [TBL] [Abstract][Full Text] [Related]
18. Association of Alterations in Intestinal Microbiota With Impaired Psychological Function in Patients With Inflammatory Bowel Diseases in Remission. Humbel F; Rieder JH; Franc Y; Juillerat P; Scharl M; Misselwitz B; Schreiner P; Begré S; Rogler G; von Känel R; Yilmaz B; Biedermann L; Clin Gastroenterol Hepatol; 2020 Aug; 18(9):2019-2029.e11. PubMed ID: 31546058 [TBL] [Abstract][Full Text] [Related]
19. Differences in Gut Microbiota in Patients With vs Without Inflammatory Bowel Diseases: A Systematic Review. Pittayanon R; Lau JT; Leontiadis GI; Tse F; Yuan Y; Surette M; Moayyedi P Gastroenterology; 2020 Mar; 158(4):930-946.e1. PubMed ID: 31812509 [TBL] [Abstract][Full Text] [Related]
20. Effects of soy milk consumption on gut microbiota, inflammatory markers, and disease severity in patients with ulcerative colitis: a study protocol for a randomized clinical trial. Sadeghi O; Milajerdi A; Siadat SD; Keshavarz SA; Sima AR; Vahedi H; Adibi P; Esmaillzadeh A Trials; 2020 Jun; 21(1):565. PubMed ID: 32576228 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]